US 10512671
IL-24 to treat inflammatory diseases
granted A61KA61K38/1774A61K38/20
Quick answer
US patent 10512671 (IL-24 to treat inflammatory diseases) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Dec 19 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Secretary, Department of Health and Human Services
- Grant date
- Tue Dec 24 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 19 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 24
- CPC classes
- A61K, A61K38/1774, A61K38/20, A61K38/22, A61K47/68